CompuMed to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006.

LOS ANGELES -- CompuMed, Inc. (OTCBB:CMPD) - a medical informatics company leading the development of advanced imaging technology for cost effective analysis and monitoring - today announced that it will present at the Rodman & Renshaw Techvest 8th Annual Healthcare Conference, on Wednesday, November 8th at 8:50 AM EST at the Palace Hotel in New York. CompuMed is among the select 300 emerging growth biotechnology companies scheduled to present at the conference, which will unite such companies with institutional investors, venture capitalists, senior corporate executives and experts from the scientific and medical communities.

Jerry McLaughlin, CompuMed's CEO, will outline the Company's growth strategy to position itself as the leading provider of remote imaging analysis in cardiology and radiology. The presentation will be webcast live and available for 90 days at http://www.wsw.com/webcast/rrshq10/cmpd.ob. More information about the conference is available at www.rodmanandrenshaw.com/us06conference.

About CompuMed:

Founded in 1973, CompuMed, Inc. (OTCBB:CMPD) is leading the development of advanced imaging and medical informatics solutions that provide cost effective analysis and monitoring. The Company focuses on cardiovascular and musculoskeletal diseases, as well as other diseases associated with aging populations. Its unique expertise in telemonitoring, imaging and analysis facilitates the development of new solutions and services designed to improve healthcare provider workflow and patient care, while reducing costs. The company's core products are the OsteoGram([R]) and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram has the additional capability to automatically provide an over-read (i.e., follow-up review) by a cardiologist. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, availability of appropriate acquisition candidates and/or business partnerships, economic conditions, impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Companies are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.